In the latest trading session,, 0.52 million Tourmaline Bio Inc (NASDAQ:TRML) shares changed hands as the company’s beta touched 2.04. With the company’s most recent per share price at $13.60 changed hands at -$3.03 or -18.22% at last look, the market valuation stands at $349.36M. TRML’s current price is a discount, trading about -119.04% off its 52-week high of $29.79. The share price had its 52-week low at $11.56, which suggests the last value was 15.0% up since then. When we look at Tourmaline Bio Inc’s average trading volume, we note the 10-day average is 0.24 million shares, with the 3-month average coming to 326.67K.
Tourmaline Bio Inc (NASDAQ:TRML) trade information
Instantly TRML was in red as seen in intraday trades today. With action -12.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -32.94%, with the 5-day performance at -12.48% in the red. However, in the 30-day time frame, Tourmaline Bio Inc (NASDAQ:TRML) is -18.85% down. Looking at the short shares, we see there were 3.19 million shares sold at short interest cover period of 8.77 days.
The consensus price target for the stock as assigned by Wall Street analysts is 50, meaning bulls need an upside of 72.8% from its recent market value. According to analyst projections, TRML’s forecast low is 42 with 50 as the target high. To hit the forecast high, the stock’s price needs a -267.65% plunge from its current level, while the stock would need to soar -208.82% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.04%. The 2025 estimates are for Tourmaline Bio Inc earnings to decrease by -20.69%, but the outlook for the next 5-year period is at -17.00% per year.
TRML Dividends
Tourmaline Bio Inc is expected to release its next quarterly earnings report on 2025-May-01.
Tourmaline Bio Inc (NASDAQ:TRML)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.93% of Tourmaline Bio Inc shares while 90.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 115.48%. There are 90.16% institutions holding the Tourmaline Bio Inc stock share, with RA CAPITAL MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 9.8699% of the shares, roughly 2.54 million TRML shares worth $32.65 million.
AVORO CAPITAL ADVISORS LLC holds the second largest percentage of outstanding shares, with 8.6387% or 2.22 million shares worth $28.58 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 647.38 shares estimated at $9.48 million under it, the former controlled 2.52% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.37% of the shares, roughly 608.6 shares worth around $8.91 million.
